Literature DB >> 12477953

Toll-like receptor 4 polymorphisms and atherogenesis.

Graham S Cooke, Shelley Segal, Adrian V S Hill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12477953     DOI： 10.1056/NEJM200212123472416

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  6 in total

Review 1.  TLR4 polymorphisms and disease susceptibility.

Authors:  Mamoona Noreen; Muhammad Ali A Shah; Sheeba Murad Mall; Shazia Choudhary; Tahir Hussain; Iltaf Ahmed; Syed Fazal Jalil; Muhammad Imran Raza
Journal:  Inflamm Res       Date:  2012-01-26       Impact factor: 4.575

2.  Toll-like receptor (TLR) 4 polymorphism Asp299Gly is not associated with disease course in Dutch sarcoidosis patients.

Authors:  M Veltkamp; J C Grutters; C H M van Moorsel; H J T Ruven; J M M van den Bosch
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

Review 3.  The role of Toll-like receptor signaling in human immunodeficiencies.

Authors:  Hanna Suhir; Amos Etzioni
Journal:  Clin Rev Allergy Immunol       Date:  2010-02       Impact factor: 8.667

4.  Toll-like receptor 4 region genetic variants are associated with susceptibility to melioidosis.

Authors:  T E West; W Chierakul; N Chantratita; D Limmathurotsakul; V Wuthiekanun; M J Emond; T R Hawn; S J Peacock; S J Skerrett
Journal:  Genes Immun       Date:  2011-07-21       Impact factor: 2.676

5.  Danger of frustrated sensors: Role of Toll-like receptors and NOD-like receptors in aseptic and septic inflammations around total hip replacements.

Authors:  Michiaki Takagi; Yuya Takakubo; Jukka Pajarinen; Yasushi Naganuma; Hiroharu Oki; Masahiro Maruyama; Stuart B Goodman
Journal:  J Orthop Translat       Date:  2017-06-07       Impact factor: 5.191

6.  Toll-like receptor and IL-12 signaling control susceptibility to contact hypersensitivity.

Authors:  Stefan F Martin; Jan C Dudda; Eva Bachtanian; Annalisa Lembo; Stefanie Liller; Christoph Dürr; Markus M Heimesaat; Stefan Bereswill; György Fejer; Ralitsa Vassileva; Thilo Jakob; Nikolaus Freudenberg; Christian C Termeer; Caroline Johner; Chris Galanos; Marina A Freudenberg
Journal:  J Exp Med       Date:  2008-08-25       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.